Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis

被引:9
作者
Harris, Melissa L. L. [1 ,2 ]
Feyissa, Tesfaye R. R. [1 ,2 ,3 ]
Bowden, Nikola A. A. [2 ,4 ]
Gemzell-Danielsson, Kristina [5 ]
Loxton, Deborah [1 ,2 ]
机构
[1] Univ Newcastle, Coll Hlth Med & Wellbeing, Ctr Womens Hlth Res, Newcastle, NSW, Australia
[2] Hunter Med Res Inst, Newcastle, NSW, Australia
[3] Deakin Univ, Fac Hlth, Sch Med, Geelong, Australia
[4] Univ Newcastle, Coll Hlth Med & Wellbeing, Ctr Drug Repurposing & Med Res, Newcastle, NSW, Australia
[5] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
基金
澳大利亚研究理事会;
关键词
Cancer; Contraception; Contraceptive counselling; Women; Interventions; BREAST-CANCER; CHILDHOOD-CANCER; UNINTENDED PREGNANCY; FEMALE SURVIVORS; INFERTILITY; OUTCOMES; ADOLESCENT; NEEDS; RISK;
D O I
10.1186/s12916-022-02690-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A lack of clarity exists regarding contraceptive uptake and counselling among women with cancer, despite these women having unique family planning needs. This study aimed to systematically review the available literature and produce an overall summary estimate of contraceptive use and counselling among women with cancer across the cancer care continuum.Methods: A systematic search of articles reporting on contraceptive counselling and/or contraceptive use among women of reproductive age (15-49 years) with cancer across the cancer care continuum (e.g. diagnosis, treatment, survivorship) was conducted in MEDLINE, Embase, CINAHL, Maternity and Infant Care and Cochrane Library. Two independent reviewers conducted the data screening, data extraction and risk of bias assessment. Qualitative synthesis and meta-analyses were conducted to summarise the key findings.Results: We included 21 articles involving 3835 participants in this review. Studies varied according to the cancer population and time along the cancer care continuum it was assessed. Of the studies that reported the overall contraceptive prevalence among women diagnosed with cancer (n = 8), contraceptive use ranged from 25 to 92%. Of the four studies that focused on cancer survivors, the contraceptive prevalence ranged from 47 to 84%. When the prevalence of these studies was pooled, a crude summary prevalence of 64% (62% among women with cancer versus 68% among cancer survivors) was found. The rate of contraceptive counselling was assessed in ten studies. A pooled prevalence of 50% (44% among women with cancer versus 58% among cancer survivors) was found, with the prevalence ranging from 12 to 78% among individual studies depending on the point in the cancer care continuum that it was provided. When contraceptive counselling was provided, it was found to significantly increase contraceptive use although biases were identified in its application.Conclusions: Contraceptive counselling interventions as part of standard cancer care have the potential to not only empower women with cancer and cancer survivors to make informed choices regarding their reproductive health but also provide the ability to plan future pregnancies for times of better health.
引用
收藏
页数:15
相关论文
共 69 条
[1]   Contraception Counseling and Use Among Adolescent and Young Adult Female Patients Undergoing Cancer Treatment: A Retrospective Analysis [J].
Abelman, Sarah H. ;
Cron, Julia .
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2020, 33 (06) :652-657
[2]   The Effects of Paclitaxel, Dose Density, and Trastuzumab on Treatment-Related Amenorrhea in Premenopausal Women With Breast Cancer [J].
Abusief, Mary E. ;
Missmer, Stacey A. ;
Ginsburg, Elizabeth S. ;
Weeks, Jane C. ;
Partridge, Ann H. .
CANCER, 2010, 116 (04) :791-798
[3]   ESHRE guideline: female fertility preservation [J].
Anderson, Richard A. ;
Amant, Frederic ;
Braat, Didi ;
D'Angelo, Arianna ;
Lopes, Susana M. Chuva de Sousa ;
Demeestere, Isabelle ;
Dwek, Sandra ;
Frith, Lucy ;
Lambertini, Matteo ;
Maslin, Caroline ;
Moura-Ramos, Mariana ;
Nogueira, Daniela ;
Rodriguez-Wallberg, Kenny ;
Vermeulen, Nathalie .
HUMAN REPRODUCTION OPEN, 2020, 2020 (04)
[4]  
[Anonymous], Intimate Partner Violence and Firearms
[5]  
AYA cancer fertility preservation guidance working group, 2014, FERTILITY PRESERVATI
[6]   Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort [J].
Barton, Sara E. ;
Najita, Julie S. ;
Ginsburg, Elizabeth S. ;
Leisenring, Wendy M. ;
Stovall, Marilyn ;
Weathers, Rita E. ;
Sklar, Charles A. ;
Robison, Leslie L. ;
Diller, Lisa .
LANCET ONCOLOGY, 2013, 14 (09) :873-881
[7]   Suboptimal Use of Effective Contraceptive Methods in Young Mexican Women With Breast Cancer [J].
Castro-Sanchez, Andrea ;
Alejandra Martinez-Cannon, Bertha ;
Platas, Alejandra ;
Mohar, Alejandro ;
Fonseca, Alan ;
Vega, Yoatzin ;
Fimbres-Morales, Adrian ;
Villarreal-Garza, Cynthia .
JOURNAL OF GLOBAL ONCOLOGY, 2018, 4 :1-7
[8]   What qualities of long-acting reversible contraception do women perceive as desirable or undesirable? A systematic review [J].
Coombe, Jacqueline ;
Harris, Melissa L. ;
Loxton, Deborah .
SEXUAL HEALTH, 2016, 13 (05) :404-419
[9]   US Medical Eligibility Criteria for Contraceptive Use, 2016 [J].
Curtis, Kathryn M. ;
Tepper, Naomi K. ;
Jatlaoui, Tara C. ;
Berry-Bibee, Erin ;
Horton, Leah G. ;
Zapata, Lauren B. ;
Simmons, Katharine B. ;
Pagano, H. Pamela ;
Jamieson, Denise J. ;
Whiteman, Maura K. .
MMWR RECOMMENDATIONS AND REPORTS, 2016, 65 (03) :1-103
[10]   Rate of abnormal vaginal bleeding and contraception counseling in women undergoing chemotherapy [J].
Cutler, Kristin E. ;
Creinin, Mitchell D. ;
Balagtas, Jay Michael S. ;
Hou, Melody Y. .
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2016, 14 (08) :337-341